InvestSMART

Tyro Payments Limited (ASX: TYR) - Announcements

- Current share price for TYR : $0.695

ASX company news and announcements for Tyro Payments Limited (TYR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Tyro Payments Limited (TYR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Tyro Payments Limited (TYR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Tyro Payments Limited (TYR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$370 Change of Director's Interest Notice - David Fite 18 Jun 2021 9:14AM $3.950 $0.695 fallen by 82.41%
$370 Notification of cessation of securities - TYR 18 Jun 2021 9:06AM $3.950 $0.695 fallen by 82.41%
$370 Application for quotation of securities - TYR 18 Jun 2021 9:05AM $3.950 $0.695 fallen by 82.41%
$370 Notification of cessation of securities - TYR 16 Jun 2021 11:41AM $3.860 $0.695 fallen by 81.99%
$370 COVID-19 Trading Update 65 - Week Ended 11 June 2021 15 Jun 2021 8:23AM $3.870 $0.695 fallen by 82.04%
$370 Application for quotation of securities - TYR 11 Jun 2021 9:38AM $3.650 $0.695 fallen by 80.96%
$370 COVID-19 Trading Update 64 - Week Ended 4 June 2021 7 Jun 2021 8:31AM $3.600 $0.695 fallen by 80.69%
$370 Tyro Payments APS330 - 31 March 2021 1 Jun 2021 5:29PM $3.720 $0.695 fallen by 81.32%
$370 Completion Merchant Acquiring Alliance - Tyro & Bendigo Bank 1 Jun 2021 5:24PM $3.720 $0.695 fallen by 81.32%
$370 Ceasing to be a substantial holder 31 May 2021 7:11PM $3.830 $0.695 fallen by 81.85%
$370 Appendix 2A 31 May 2021 6:53PM $3.830 $0.695 fallen by 81.85%
$370 Update - Proposed issue of Securities - TYR 31 May 2021 6:53PM $3.830 $0.695 fallen by 81.85%
$370 Tyro Completes Acquisition of Health Fintech - Medipass 31 May 2021 6:41PM $3.830 $0.695 fallen by 81.85%
$370 COVID-19 Trading Update 63 - Week Ended 28 May 2021 31 May 2021 8:23AM $3.910 $0.695 fallen by 82.23%
$370 Update - Status of Make Good Actions 27 May 2021 9:12AM $3.840 $0.695 fallen by 81.90%
$370 Appendix 2A 26 May 2021 8:23AM $3.810 $0.695 fallen by 81.76%
$370 COVID-19 Trading Update 62 - Week Ended 21 May 2021 24 May 2021 8:31AM $3.760 $0.695 fallen by 81.52%
$370 Change of Director's Interest Notice - David Fite 19 May 2021 8:24AM $3.720 $0.695 fallen by 81.32%
$370 COVID-19 Trading Update 61 - Week Ended 14 May 2021 17 May 2021 8:29AM $3.680 $0.695 fallen by 81.11%
$370 Appendix 2A 13 May 2021 8:56AM $3.750 $0.695 fallen by 81.47%
$370 Proposed issue of Securities - TYR 13 May 2021 8:54AM $3.750 $0.695 fallen by 81.47%
$370 Proposed issue of Securities - TYR 13 May 2021 8:53AM $3.750 $0.695 fallen by 81.47%
$370 Proposed issue of Securities - TYR 10 May 2021 10:02AM $3.420 $0.695 fallen by 79.68%
$370 Tyro to Acquire Health Fintech - Medipass 10 May 2021 9:40AM $3.420 $0.695 fallen by 79.68%
$370 COVID-19 Trading Update 60 - Week Ended 7 May 2021 10 May 2021 9:09AM $3.420 $0.695 fallen by 79.68%

426 - 450 of 648 results

Page 18 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.